article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. NYSE: AMAM), a position he previously held from 2010 through 2015. We are currently focused on developing the first FDA-approved therapy for emergency department physicians to treat the serious and sometimes fatal effects of cannabinoid intoxication.

article thumbnail

Scientists Think the Synthetic Cannabinoids in Sativex Can Beat Brain Cancer

SpeedWeed

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . “It’s not just street cannabis put into a bottle,” GW Pharmaceutical CEO Justin Gover once told the Guardian. View original article.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

article thumbnail

Can cannabis reduce acid reflux?

The Cannigma

6 medicinal plants that pharmaceuticals can't replace. A 2017 review of research surrounding the ECS and the esophagus noted, “The presence of cannabinoid receptors in the esophagus, specifically those affecting [esophageal relaxation], offers a potential therapeutic target for treating GERD.”. Related Stories.

Digestion 119
article thumbnail

GW suffers major blow as US sinks bid to patent cannabinoids for epilepsy

Cannabis Law Report

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

article thumbnail

From MMJ to Special K

Project CBD

He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals. According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.”

article thumbnail

Study: Marijuana Decreases Migraine Pain

CannaMD

Unfortunately, most traditional pharmaceutical options are distinctly lacking due to side effects, as well as a bit of trepidation (although Botox, one current treatment option for migraines, has gained popularity). The study appeared in the peer-reviewed journal, Pharmacotherapy , and followed migraine patients between 2010 and 2014.

Marijuana 116